Buyers in healthcare use generic drug competition to drive down prescription prices, saving billions. Learn how Medicare, Canada, and other systems leverage competition to lower costs - and why corporate tactics threaten its effectiveness.
Providers face growing barriers securing approval for generic medications despite their lower cost. Learn how documentation, electronic systems, and payer policies shape the process-and what’s changing in 2025.
Many people stop taking generic medications because they don't understand they're the same as brand-name drugs. Learn how health literacy gaps lead to dangerous misunderstandings-and what you can do to stay safe and save money.